GlassScriptPhysician profile
Matthew Mason
NPI 1235663022
$984.20
in general payments reported to CMS, 2019-2025
17 companies · $462 in 2025
The $462 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.71 · 2023: $16.72 · 2024: $480 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $860 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.50 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $214.82 | 2024-2025 | Veozah |
| Novo Nordisk INC | $147.37 | 2024 | Wegovy |
| Shield Therapeutics INC | $123.25 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $105.65 | 2025 | Myfembree |
| Sage Therapeutics, LLC | $77.45 | 2025 | Zurzuvae |
| Pfizer INC. | $47.38 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $43.51 | 2024-2025 | |
| Lilly USA, LLC | $41.37 | 2025 | Zepbound, Mounjaro |
| Millicent US INC | $33.17 | 2023-2024 | Intrarosa, Femring |
| Agile Therapeutics, INC. | $24.71 | 2022 | |
| Biogen, INC. | $24.52 | 2024 | Zurzuvae |
| Exeltis, USA INC. | $23.77 | 2024 | Slynd |
| Teleflex LLC | $19.90 | 2024 | Arrow |
| Abbvie INC. | $17.34 | 2025 | |
| Evofem Biosciences, INC. | $15.57 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.67 | 2024 | Cologuard Collection Kit |
| Organon LLC | $10.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.